ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,514.00
      1.00%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      0.00%
      Bitcoin
      67,814.18
      -0.15%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Akari Therapeutics PLC (AKTX)

      7. Akari Therapeutics PLC (AKTX) Financials

      Akari Therapeutics PLC

      Akari Therapeutics PLC (AKTX)

      NASDAQ
      4.25
      0.2567
      (6.43%)
      Closed July 27 4:00PM
      Delayed by 15 minutes
      4.25
      0.00
      (0.00%)
      After Hours: 5:45PM
      Delayed by 15 minutes

      Akari Therapeutics PLC Financial Summary

      The current AKTX market cap is 33.68M. The company's latest EPS is USD -1.2630 and P/E is -3.37.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -4.33M-1.46M-5.9M-5.24M-5.82M
      Net Income -4.35M-1.45M-5.79M-5.18M-5.68M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 199k556k00199k
      Operating Income -16.78M-17.45M-17.24M-25.4M-16.61M
      Net Income -16.85M-17.08M-17.42M-17.01M-10.01M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 4.83M14.72M11.65M19.46M11.37M
      Total Liabilities 3.24M3.36M6.09M5.52M3.05M
      Total Equity 1.59M11.36M5.56M13.93M8.33M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 6.48M14.61M11.65M16.22M4.36M
      Total Liabilities 6.47M5.22M6.09M10.98M4.58M
      Total Equity 8k9.38M5.56M5.24M-229k

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -12.28M-13.84M N/A -5.05M-13.62M
      Investing N/A N/A N/A N/A N/A
      Financing 1.99M13.18M N/A 12.37M12.37M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -12.92M-16.95M-18.85M-21.5M N/A
      Investing N/A N/A N/A N/A N/A
      Financing 12.65M25.07M14.29M25.29M N/A

      Stats and Ratios

      Market Cap 33.68M
      Price to Earnings Ratio -3.37
      Price to Sales Ratio 169.32
      Price to Cash Ratio 8.76
      Price to Book Ratio -147.06
      Dividend Yield -

      Share Statistics

      Shares Outstanding 7.92M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.39 (8.86%)

      Company Info

      Company Name Akari Therapeutics PLC
      Address highdown house yeoman
      west sussex BN99 3HH
      Website https://www.akaritx.com
      Industry coml physical, biologcl resh (8731)